So we are on the verge of Euro approval and sales commencing in June. And we are at a 52 week low?
I guess I need to take the rose coloured glasses off - but I can't understand why the market is not interested in TIS.
Is approval or sales so uncertain?
Most other biotechs seem to be moving north apart from TIS.
I topped up at 41 but that's pretty much it for me now.